Development and Evaluation of an Index to Measure the Ability to Get Vaccinated for COVID-19
Abstract
:1. Introduction
2. Methods
2.1. Design
2.2. Measures and Item Development
2.3. Data Collection
2.4. Data Analysis
3. Results
3.1. Validity of the Ability Items
3.2. Derivation of the Ability Index
3.3. Validity of the Ability Index
4. Discussion
Limitations of the Current Research
5. Conclusions
Supplementary Materials
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Conflicts of Interest
References
- Glanz, K.; Bishop, D.B. The Role of Behavioral Science Theory in Development and Implementation of Public Health Interventions. Annu. Rev. Public Health 2010, 31, 399–418. [Google Scholar] [CrossRef]
- Davis, R.; Campbell, R.; Hildon, Z.; Hobbs, L.; Michie, S. Theories of behaviour and behaviour change across the social and behavioural sciences: A scoping review. Health Psychol. Rev. 2014, 9, 323–344. [Google Scholar] [CrossRef]
- Evans, W.D.; Gerard, R.; Symington, L.; Shaikh, H.; Agha, S. Implementation practice models for development in low- and middle-income countries: Systematic review of peer-reviewed literature. BMC Public Health 2022, 22, 1157. [Google Scholar] [CrossRef]
- MacInnis, D.J.; Moorman, C.; Jaworski, B.J. Enhancing and measuring consumers’ motivation, opportunity, and ability to process brand information from ads. J. Mark. 1995, 55, 32–53. [Google Scholar] [CrossRef]
- Rothschild, M.L. Carrots, Sticks, and Promises: A Conceptual Framework for the Management of Public Health and Social Issue Behaviors. J. Mark. 1999, 63, 24–37. [Google Scholar] [CrossRef]
- Willmott, T.; Parkinson, J. Motivation, opportunity, and ability: Understanding new habits and changes adopted for weight management. Int. J. Consum. Stud. 2017, 41, 291–298. [Google Scholar] [CrossRef]
- French, J.; Deshpande, S.; Evans, W.; Obregon, R. Key Guidelines in Developing a Pre-Emptive COVID-19 Vaccination Uptake Promotion Strategy. Int. J. Environ. Res. Public Health 2020, 17, 5893. [Google Scholar] [CrossRef]
- Rogers, E.M. Diffusion of Innovations, 5th ed.; Free Press: New York, NY, USA, 2003. [Google Scholar]
- Evans, W.D.; French, J. Demand Creation for COVID-19 Vaccination: Overcoming Vaccine Hesitancy through Social Marketing. Vaccines 2021, 9, 319. [Google Scholar] [CrossRef]
- Olander, F.; Thorgesen, J. Understanding of consumer behaviour as pre-requisite for environmental protection. J. Consum. Policy 1995, 18, 345–385. [Google Scholar] [CrossRef]
- Razai, M.S.; Oakeshott, P.; Esmail, A.; Wiysonge, C.S.; Viswanath, K.; Mills, M.C. COVID-19 vaccine hesitancy: The five Cs to tackle behavioural and sociodemographic factors. J. R. Soc. Med. 2021, 114, 295–298. [Google Scholar] [CrossRef]
- Freeman, D.; Loe, B.S.; Chadwick, A.; Vaccari, C.; Waite, F.; Rosebrock, L.; Jenner, L.; Petit, A.; Lewandowsky, S.; Vanderslott, S.; et al. COVID-19 vaccine hesitancy in the UK: The Oxford coronavirus explanations, attitudes, and narratives survey (Oceans) II. Psychol. Med. 2022, 52, 3127–3141. [Google Scholar] [CrossRef]
- Betsch, C.; Schmid, P.; Heinemeier, D.; Korn, L.; Holtmann, C.; Böhm, R. Beyond confidence: Development of a measure assessing the 5C psychological antecedents of vaccination. PLoS ONE 2018, 13, e0208601. [Google Scholar] [CrossRef]
- Barnett, D.J.; Errett, N.A.; Rutkow, L. A Threat- Efficacy-based Framework to Understand Confidence in Vaccines among the Public Health Workforce. Vaccines 2013, 1, 77–87. [Google Scholar] [CrossRef]
- Costenbader, E.; Cislaghi, B.; Clark, C.J.; Hinson, L.; Lenzi, R.; McCarraher, D.R.; McLarnon-Silk, C.; Pulerwitz, J.; Shaw, B.; Stefanik, L. Social Norms Measurement: Catching up With Programs and Moving the Field Forward. J. Adolesc. Health 2019, 64, S4–S6. [Google Scholar] [CrossRef]
- Sedlander, E.; Bingenheimer, J.B.; Long, M.W.; Swain, M.; Rimal, R.N. The G-NORM Scale: Development and Validation of a Theory-Based Gender Norms Scale. Sex Roles 2022, 87, 350–363. [Google Scholar] [CrossRef]
- Michie, S.; van Stralen, M.M.; West, R. The behaviour change wheel: A new method for characterising and designing behaviour change interventions. Implement. Sci. 2011, 6, 42. [Google Scholar] [CrossRef]
- Bollen, K.; Diamantopoulos, A. In defense of causal-formative indicators: A minority report. Psychol. Methods 2017, 22, 581–596. [Google Scholar] [CrossRef]
- DeVellis, R.F.; Thorpe, C.T. Scale Development: Theory and Applications, 5th ed.; Sage: Thousand Oaks, CA, USA, 2022. [Google Scholar]
- Diamantopoulos, A.; Siguaw, J.A. Formative versus reflective indicators in organizational measurement development: A comparison and empirical illustration. Br. J. Manag. 2006, 17, 263–282. [Google Scholar] [CrossRef]
- Edwards, J.R.; Bagozzi, R.P. On the nature and direction of relationships between constructs and measures. Psychol. Methods 2000, 5, 155–174. [Google Scholar] [CrossRef]
- Li, L.; Wood, C.E.; Kostkova, P. Vaccine hesitancy and behavior change theory-based social media interventions: A systematic review. Transl. Behav. Med. 2022, 12, 243–272. [Google Scholar] [CrossRef]
- Shen, S.C.; Dubey, V. Addressing vaccine hesitancy: Clinical guidance for primary care physicians working with parents. Can. Fam. Physician 2019, 65, 175–181. [Google Scholar]
- Dubé, E.; Laberge, C.; Guay, M.; Bramadat, P.; Roy, R.; Bettinger, J. Vaccine hesitancy: An overview. Hum. Vaccin. Immunother. 2013, 9, 1763–1773. [Google Scholar] [CrossRef]
- Hudson, A.; Montelpare, W.J. Predictors of Vaccine Hesitancy: Implications for COVID-19 Public Health Messaging. Int. J. Enviorn. Res. Public Health 2021, 18, 8054. [Google Scholar] [CrossRef] [PubMed]
- Freeman, D.; Loe, B.S.; Yu, L.M.; Freeman, J.; Chadwick, A.; Vaccari, C.; Shanyinde, M.; Harris, V.; Waite, F.; Rosebrock, L.; et al. Effects of different types of written vaccination information on COVID-19 vaccine hesitancy in the UK (OCEANS-III): A single-blind, parallel-group, randomised controlled trial. Lancet Public Health 2021, 6, e416–e427. [Google Scholar] [CrossRef]
- Thaker, J.; Richardson, L.M.; Holmes, D.C. Audience segmentation analysis of public intentions to get a COVID-19 vaccine in Australia. Public Underst. Sci. 2022, 9636625221138494, epub ahead of print. [Google Scholar] [CrossRef]
- Saul, H.; Gursul, D. Stressing the personal benefits of the covid-19 vaccine might encourage more people to accept it. BMJ 2021, 375, n2923. [Google Scholar] [CrossRef] [PubMed]
- Lahariya, C.; Paruthi, P.; Bhattacharya, M. How a new health intervention affects the health system? Learnings from pentavalent vaccine introduction in India. Indian J. Pediatr. 2016, 83, 294–299. [Google Scholar] [CrossRef]
- Arede, M.; Bravo-Araya, M.; Bouchard, É.; Gill, G.S.; Plajer, V.; Shehraj, A.; Shuaib, Y.A. Combating Vaccine Hesitancy: Teaching the Next Generation to Navigate Through the Post Truth Era. Front. Public Health 2019, 6, 381. [Google Scholar] [CrossRef] [Green Version]
Age in Years | n | % |
---|---|---|
18–29 | 469 | 60.1 |
30–39 | 230 | 29.5 |
40–49 | 60 | 7.7 |
50–59 | 18 | 2.3 |
60+ | 4 | 0.5 |
Education | ||
Primary or secondary school | 121 | 15.5 |
Diploma | 180 | 23.1 |
Bachelors | 349 | 44.7 |
Masters | 78 | 10.0 |
PhD | 17 | 2.2 |
Other | 36 | 4.6 |
Gender | ||
Man | 502 | 64.3 |
Woman | 267 | 34.2 |
Prefer not to say | 12 | 1.5 |
Employment | ||
Not a health sector worker | 405 | 51.9 |
Nurse/midwife | 70 | 9.0 |
Community health worker | 64 | 8.2 |
Laboratory staff | 56 | 7.2 |
Medical doctor | 55 | 7.0 |
Pharmacist | 35 | 4.5 |
PPMV/chemists | 16 | 2.1 |
Other health sector worker | 80 | 10.2 |
Religion | ||
Christian (not Catholic) | 391 | 50.1 |
Muslim | 219 | 28.0 |
Catholic | 152 | 19.5 |
Other | 19 | 2.4 |
Vaccination Status | ||
Not vaccinated | 297 | 38.0 |
Vaccinated | 484 | 62.0 |
Strongly Agree | Agree | Neutral | Disagree | Strongly Disagree | |
---|---|---|---|---|---|
1. My family and household responsibilities make it difficult for me to find time to get a COVID-19 vaccine. | 17 | 80 | 108 | 334 | 242 |
(2.2) | (10.2) | (13.8) | (42.8) | (31.0) | |
2. I can leave my work long enough to get the COVID-19 vaccine. | 123 | 317 | 160 | 120 | 61 |
(15.8) | (40.6) | (20.5) | (15.4) | (7.8) | |
3. The COVID-19 vaccine is affordable to me. | 121 | 329 | 152 | 114 | 65 |
(15.5) | (42.1) | (19.5) | (14.6) | (8.3) | |
4. I would lose income by taking time to get the COVID-19 vaccine. | 22 | 131 | 129 | 313 | 186 |
(2.8) | (16.8) | (16.5) | (40.1) | (23.8) | |
5. My supervisor would support my getting the COVID-19 vaccine. | 208 | 324 | 148 | 46 | 55 |
(26.6) | (41.5) | (19.0) | (5.9) | (7.0) | |
6. The COVID-19 vaccine is conveniently available to me. | 102 | 340 | 129 | 158 | 52 |
(13.1) | (43.5) | (16.5) | (20.2) | (6.7) | |
7. I have to travel a long way to get the COVID-19 vaccine. | 43 | 182 | 97 | 323 | 136 |
(5.5) | (23.3) | (12.4) | (41.4) | (17.4) | |
8. I am worried that side effects of the COVID-19 vaccine would make it difficult for me to fulfill my work or family responsibilities. | 49 | 219 | 156 | 233 | 124 |
(6.3) | (28.0) | (20.0) | (29.8) | (15.9) | |
9. The decision to get the COVID-19 vaccine is difficult. | 46 | 190 | 126 | 294 | 125 |
(5.9) | (24.3) | (16.1) | (37.6) | (16.0) | |
10. I have a spouse/partner who would not approve of me getting a COVID-19 vaccination. | 40 | 87 | 135 | 315 | 204 |
(5.1) | (11.1) | (17.3) | (40.3) | (26.1) | |
11. I know where to go to get the COVID-19 vaccine. | 157 | 367 | 77 | 119 | 61 |
(20.1) | (47.0) | (9.9) | (15.2) | (7.8) | |
12. It would require a big change in my daily routine to get the COVID-19 vaccine. | 45 | 224 | 149 | 269 | 94 |
(5.8) | (28.7) | (19.1) | (34.4) | (12.0) |
Twelve Ability Index Items | OR | (95% C.I.) |
---|---|---|
1. My family and household responsibilities make it difficult for me to find time to get a COVID-19 vaccine. | 1.43 | (1.24–1.65) *** |
2. I can leave my work long enough to get the COVID-19 vaccine. | 1.34 | (1.18–1.52) *** |
3. The COVID-19 vaccine is affordable to me. | 1.54 | (1.35–1.75) *** |
4. I would lose income by taking time to get the COVID-19 vaccine. | 1.24 | (1.09–1.41) ** |
5. My supervisor would support my getting the COVID-19 vaccine. | 1.44 | (1.26–1.65) *** |
6. The COVID-19 vaccine is conveniently available to me. | 1.92 | (1.67–2.21) *** |
7. I have to travel a long way to get the COVID-19 vaccine. | 1.31 | (1.16–1.49) *** |
8. I am worried that side effects of the COVID-19 vaccine would make it difficult for me to fulfill my work or family responsibilities. | 1.62 | (1.42–1.84) *** |
9. The decision to get the COVID-19 vaccine is difficult. | 1.46 | (1.29–1.66) *** |
10. I have a spouse/partner who would not approve of me getting a COVID-19 vaccination. | 1.09 | (0.96–1.24) |
11. I know where to go to get the COVID-19 vaccine. | 1.57 | (1.39–1.79) *** |
12. It would require a big change in my daily routine to get the COVID-19 vaccine. | 1.27 | (1.12–1.45) *** |
AOR | (95% C.I.) | |
---|---|---|
1. My family and household responsibilities make it difficult for me to find time to get a COVID-19 vaccine. | 1.23 | (0.97–1.56) |
2. I can leave my work long enough to get the COVID-19 vaccine. | 1.20 | (0.95–1.52) |
3. The COVID-19 vaccine is affordable to me. | 1.15 | (0.90–1.47) |
4. I would lose income by taking time to get the COVID-19 vaccine. | 1.01 | (0.79–1.29) |
5. My supervisor would support my getting the COVID-19 vaccine. | 0.95 | (0.73–1.22) |
6. The COVID-19 vaccine is conveniently available to me. | 1.85 | (1.41–2.44) *** |
7. I have to travel a long way to get the COVID-19 vaccine. | 0.94 | (0.74–1.19) |
8. I am worried that side effects of the COVID-19 vaccine would make it difficult for me to fulfill my work or family responsibilities. | 1.40 | (1.11–1.75) ** |
9. The decision to get the COVID-19 vaccine is difficult. | 1.14 | (0.91–1.44) |
10. I have a spouse/partner who would not approve of me getting a COVID-19 vaccination. | 0.88 | (0.70–1.10) |
11. I know where to go to get the COVID-19 vaccine. | 1.12 | (0.89–1.41) |
12. It would require a big change in my daily routine to get the COVID-19 vaccine. | 1.04 | (0.82–1.33) |
Version 1 | Version 2 | |
---|---|---|
I am confident that COVID-19 vaccines are safe and effective. | 0.18 *** | 0.15 ** |
Vaccination against COVID-19 is unnecessary. | −0.32 *** | −0.22 *** |
Everyday stress prevents me from getting a COVID-19 vaccine. | −0.36 *** | −0.25 *** |
When I think about getting vaccinated against COVID-19, I weigh the benefits and risks to make the best decision possible. | −0.03 | −0.03 |
When everyone is vaccinated against COVID-19, I don’t have to get vaccinated too. | −0.40 *** | −0.25 *** |
Your friends think it is important for everyone to get a COVID-19 vaccine. | 0.28 *** | 0.22 *** |
Your family members think it is important for everyone to get a COVID-19 vaccine. | 0.38 *** | 0.33 *** |
Of the people close to you, what proportion of them would want you to get the COVID-19 vaccine? | 0.10 * | 0.07 |
How many people in Nigeria do you think will get the COVID-19 vaccine when it becomes available? | 0.03 | −0.00 |
How many people who work in healthcare in Nigeria do you think will get the COVID-19 vaccine when it becomes available? | 0.13 * | 0.08 |
Model 0 | Model 1 | Model 2 | Model 3 | Model 4 | Model 5 | Model 6 | Model 7 | Model 8 | Model 9 | Model 10 | Model 11 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
A. Unweighted Index | ||||||||||||
Ability Index | 2.20 *** | 2.18 *** | 2.20 *** | 2.00 *** | 2.20 *** | 2.13 *** | 2.20 *** | 2.09 *** | 2.20 *** | 2.20 *** | 2.21 *** | 1.92 *** |
Confidence | 1.05 | 1.06 | ||||||||||
Complacency | 1.00 | 1.10 | ||||||||||
Lack of Convenience | 0.74 *** | 0.72 *** | ||||||||||
Calculation | 0.86 | 0.83 | ||||||||||
Collective Responsibility | 0.92 | 1.01 | ||||||||||
Friends | 1.00 | 0.94 | ||||||||||
Family | 1.16 | 1.27 | ||||||||||
People Close to You | 0.99 | 1.99 | ||||||||||
Nigerians | 1.02 | 1.03 | ||||||||||
Health Care Workers | 0.96 | 0.94 | ||||||||||
B. Weighted Index | ||||||||||||
Ability Index | 2.46 *** | 2.44 *** | 2.43 *** | 2.35 *** | 2.47 *** | 2.37 *** | 2.45 *** | 2.35 *** | 2.46 *** | 2.46 *** | 2.46 *** | 2.43 *** |
Confidence | 1.05 | 1.06 | ||||||||||
Complacency | 0.95 | 1.09 | ||||||||||
Lack of Convenience | 0.69 ** | 0.70 ** | ||||||||||
Calculation | 0.85 | 0.84 | ||||||||||
Collective Responsibility | 0.84 | 0.94 | ||||||||||
Friends | 1.02 | 0.95 | ||||||||||
Family | 1.16 | 1.24 | ||||||||||
People Close to You | 1.00 | 0.99 | ||||||||||
Nigerians | 1.05 | 1.05 | ||||||||||
Health Care Workers | 0.98 | 0.96 |
Model 0 | Model 1 | Model 2 | Model 3 | Model 4 | Model 5 | Model 6 | Model 7 | Model 8 | Model 9 | Model 10 | Model 11 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
A. Unweighted Index | 1.28 | 1.24 | 1.26 | 1.27 | 1.28 | 1.27 | 1.25 | 1.28 | 1.23 | 1.29 | 1.30 | 1.29 |
Ability Index | 1.14 | 1.14 | ||||||||||
Confidence | 0.68 * | 0.60 ** | ||||||||||
Complacency | 0.88 | 0.88 | ||||||||||
Lack of Convenience | 1.13 | 1.12 | ||||||||||
Calculation | 0.95 | 1.26 | ||||||||||
Collective Responsibility | 1.14 | 1.11 | ||||||||||
Friends | 1.00 | 0.84 | ||||||||||
Family | 1.21 | 1.15 | ||||||||||
People Close to You | 0.96 | 0.89 | ||||||||||
Nigerians | 1.15 | 1.20 | ||||||||||
Health Care Workers | ||||||||||||
B. Weighted Index | ||||||||||||
Ability Index | 1.38 | 1.35 | 1.34 | 1.38 | 1.38 | 1.37 | 1.36 | 1.38 | 1.31 | 1.39 | 1.39 | 1.32 |
Confidence | 1.14 | 1.15 | ||||||||||
Complacency | 0.68 * | 0.61 * | ||||||||||
Lack of Convenience | 0.87 | 0.87 | ||||||||||
Calculation | 1.13 | 1.13 | ||||||||||
Collective Responsibility | 0.95 | 1.24 | ||||||||||
Friends | 1.14 | 1.12 | ||||||||||
Family | 1.02 | 0.86 | ||||||||||
People Close to You | 1.19 | 1.14 | ||||||||||
Nigerians | 0.95 | 0.89 | ||||||||||
Health Care Workers | 1.15 | 1.19 |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Evans, W.D.; Bingenheimer, J.B.; Long, M.; Ndiaye, K.; Donati, D.; Rao, N.M.; Akaba, S.; Hoglin, B. Development and Evaluation of an Index to Measure the Ability to Get Vaccinated for COVID-19. Vaccines 2023, 11, 342. https://doi.org/10.3390/vaccines11020342
Evans WD, Bingenheimer JB, Long M, Ndiaye K, Donati D, Rao NM, Akaba S, Hoglin B. Development and Evaluation of an Index to Measure the Ability to Get Vaccinated for COVID-19. Vaccines. 2023; 11(2):342. https://doi.org/10.3390/vaccines11020342
Chicago/Turabian StyleEvans, William D., Jeffrey B. Bingenheimer, Michael Long, Khadi Ndiaye, Dante Donati, Nandan M. Rao, Selinam Akaba, and Bailey Hoglin. 2023. "Development and Evaluation of an Index to Measure the Ability to Get Vaccinated for COVID-19" Vaccines 11, no. 2: 342. https://doi.org/10.3390/vaccines11020342
APA StyleEvans, W. D., Bingenheimer, J. B., Long, M., Ndiaye, K., Donati, D., Rao, N. M., Akaba, S., & Hoglin, B. (2023). Development and Evaluation of an Index to Measure the Ability to Get Vaccinated for COVID-19. Vaccines, 11(2), 342. https://doi.org/10.3390/vaccines11020342